TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has issued an announcement.
Jiangsu Recbio Technology Co., Ltd. has announced its 2024 Annual General Meeting scheduled for June 20, 2025, where various resolutions will be considered, including financial reports, profit distribution plans, and changes in business scope. The meeting’s outcomes could significantly impact the company’s strategic direction and stakeholder interests, particularly with resolutions on share issuance and amendments to the Articles of Association.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the biotechnology industry, focusing on medical technology and innovation.
Average Trading Volume: 94,656
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.01B
For detailed information about 2179 stock, go to TipRanks’ Stock Analysis page.